➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Merck
AstraZeneca
Harvard Business School
McKesson

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Aspirin; dipyridamole - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for aspirin; dipyridamole and what is the scope of freedom to operate?

Aspirin; dipyridamole is the generic ingredient in two branded drugs marketed by Boehringer Ingelheim, Amneal Pharms, Ani Pharms, Barr, Dr Reddys, Glenmark Pharms Sa, Lannett Co Inc, Micro Labs, Par Pharm Inc, Sandoz Inc, Sun Pharm, and Zydus Pharms, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for aspirin; dipyridamole. Fourteen suppliers are listed for this compound.

Recent Clinical Trials for aspirin; dipyridamole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rutgers, The State University of New JerseyPhase 3
RĂ©gion Hauts de France, FrancePhase 3
University Hospital, LillePhase 3

See all aspirin; dipyridamole clinical trials

Paragraph IV (Patent) Challenges for ASPIRIN; DIPYRIDAMOLE
Tradename Dosage Ingredient NDA Submissiondate
AGGRENOX CAPSULE, EXTENDED RELEASE;ORAL aspirin; dipyridamole 020884 2007-02-01

US Patents and Regulatory Information for aspirin; dipyridamole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206392-001 Mar 8, 2016 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Glenmark Pharms Sa ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 210318-001 May 24, 2019 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Boehringer Ingelheim AGGRENOX aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 020884-001 Nov 22, 1999 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Dr Reddys ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 209048-001 Oct 10, 2018 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Par Pharm Inc ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 207944-001 Jan 18, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Merck
AstraZeneca
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.